logologo
QuantliQuantli

Inovio Pharmaceuticals Inc

INO

NASDAQ

Biotechnology

$1.09

USD

+0.19 (+21.10%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $93.07M

Volume 12.1M

Price Target

$2.50$2.50

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $2.50 and a min estimate of $2.50.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$2.50

Implied Upside

+129.4%

Analyst Covering

1

Consensus

Hold

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Hold

0 Buy

1 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Raghuram Selvaraju

HC Wainwright & Co.

Hold

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BMEA

Biomea Fusion Inc

$1.32

+3.1%

XGN

Exagen Inc

$6.66

+1.2%

GNLX

Genelux Corp

$2.74

+4.2%

CADL

Candel Therapeutics Inc

$11.72

-0.7%

COYA

Coya Therapeutics Inc

$4.79

+2.6%

ANIX

Anixa Biosciences Inc

$3.18

-0.6%

FBIO

Fortress Biotech Inc

$2.93

-1.7%

BDTX

Black Diamond Therapeutics Inc

$2.02

0.0%